Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-18

Clinical Trial Update: Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of farudodstat versus placebo in adults with alopecia areata.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Farudodstat (farudodstat)

Snippet

Sponsor: ASLAN Pharmaceuticals | Conditions: Alopecia Areata | Phase 2 | Status: UNKNOWN